Evidence map›Paper›PMID 42199038›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Palladium-Catalyzed Regiodivergent Telomerization of Isoprene With Oxindoles.

Ying-Ying Liu, Shao-Han Sun, Xue-Ting Li, Zhi-Hui Wang, Ding-Wei Ji, Xiang-Ping Hu, Qing-An Chen

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ying-Ying LiuDalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, People's Republic of China.
Shao-Han SunDalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, People's Republic of China.
Xue-Ting LiDalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, People's Republic of China.
Zhi-Hui WangDalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, People's Republic of China.
Ding-Wei JiDalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, People's Republic of China.ORCID https://orcid.org/0000-0002-7734-2418
Xiang-Ping HuDalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, People's Republic of China.ORCID https://orcid.org/0000-0002-8214-1338
Qing-An ChenDalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, People's Republic of China.ORCID https://orcid.org/0000-0002-9129-2656

Funding

National Natural Science Foundation of China 22201281National Natural Science Foundation of China 22371275
6 · The paper itself

Abstract

Transition metal-catalyzed nucleophilic telomerization of isoprene is an efficient strategy for the construction of monoterpene skeletons, yet its development has been impeded by inherent challenges of chemo- and regioselectivity control, especially in reactions with carbon nucleophiles. Herein, we developed a versatile palladium catalysis for the regiodivergent telomerization of isoprene with oxindoles through synergistic control of ligands, solvents, and additives. In the presence of aprotic solvent NMP, we revealed the electron-rich and less bulky tri(2-furyl)phosphine (TFP) ligand can facilitate the exclusive formation of tail-to-tail geranyl oxindoles, meanwhile the reactivity was severely improved by adding base as additive. On the other hand, a newly designed hemilabile phosphine ligand enables selective access to tail-to-head isomer, where the MeOH worked as an irreplaceable solvent choice. Mechanistic experiments and density functional theory (DFT) calculations were conducted, which indicate that protolysis of the η

Indexed as

BPMO ligandsDFT analysisisoprenetelomerization

Identifiers

PMID42199038
PMCPMC13383255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.